Annual FCF
$276.39 M
+$301.88 M+1184.09%
31 December 2023
Summary:
Amneal Pharmaceuticals annual free cash flow is currently $276.39 million, with the most recent change of +$301.88 million (+1184.09%) on 31 December 2023. During the last 3 years, it has fallen by -$36.43 million (-11.64%). AMRX annual FCF is now -11.64% below its all-time high of $312.81 million, reached on 31 December 2020.AMRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$121.06 M
+$92.86 M+329.25%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly free cash flow is currently $121.06 million, with the most recent change of +$92.86 million (+329.25%) on 30 September 2024. Over the past year, it has increased by +$53.15 million (+78.27%). AMRX quarterly FCF is now -49.48% below its all-time high of $239.63 million, reached on 31 December 2018.AMRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$229.23 M
+$53.15 M+30.19%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM free cash flow is currently $229.23 million, with the most recent change of +$53.15 million (+30.19%) on 30 September 2024. Over the past year, it has increased by +$91.73 million (+66.71%). AMRX TTM FCF is now -43.77% below its all-time high of $407.64 million, reached on 31 March 2021.AMRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1184.1% | +78.3% | +66.7% |
| 3 y3 years | -11.6% | +71.2% | +4.5% |
| 5 y5 years | +80.5% | -4.6% | +14.9% |
AMRX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.6% | +1184.1% | -5.4% | +184.9% | -17.1% | +999.1% |
| 5 y | 5 years | -11.6% | +388.7% | -29.1% | +184.9% | -43.8% | +339.5% |
| alltime | all time | -11.6% | +388.7% | -49.5% | +184.9% | -43.8% | +306.2% |
Amneal Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $121.06 M(+329.3%) | $229.23 M(+30.2%) |
| June 2024 | - | $28.20 M(-216.7%) | $176.07 M(+41.7%) |
| Mar 2024 | - | -$24.17 M(-123.2%) | $124.24 M(-55.0%) |
| Dec 2023 | $276.39 M(-1184.1%) | $104.13 M(+53.3%) | $276.39 M(+101.0%) |
| Sept 2023 | - | $67.91 M(-387.4%) | $137.50 M(+20.8%) |
| June 2023 | - | -$23.63 M(-118.5%) | $113.83 M(-2296.6%) |
| Mar 2023 | - | $127.97 M(-468.2%) | -$5.18 M(-79.7%) |
| Dec 2022 | -$25.50 M(-113.5%) | -$34.76 M(-178.6%) | -$25.50 M(-147.9%) |
| Sept 2022 | - | $44.24 M(-131.0%) | $53.27 M(-33.2%) |
| June 2022 | - | -$142.64 M(-232.5%) | $79.76 M(-50.6%) |
| Mar 2022 | - | $107.66 M(+144.6%) | $161.41 M(-14.7%) |
| Dec 2021 | $189.18 M | $44.01 M(-37.8%) | $189.18 M(-13.7%) |
| Sept 2021 | - | $70.73 M(-216.0%) | $219.34 M(+24.7%) |
| June 2021 | - | -$60.99 M(-145.0%) | $175.96 M(-56.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $135.44 M(+82.6%) | $407.64 M(+30.3%) |
| Dec 2020 | $312.81 M(-426.8%) | $74.16 M(+171.1%) | $312.81 M(+70.9%) |
| Sept 2020 | - | $27.35 M(-84.0%) | $183.00 M(-35.2%) |
| June 2020 | - | $170.69 M(+320.3%) | $282.52 M(+296.3%) |
| Mar 2020 | - | $40.61 M(-173.0%) | $71.28 M(-174.5%) |
| Dec 2019 | -$95.73 M(-162.5%) | -$55.66 M(-143.9%) | -$95.73 M(-148.0%) |
| Sept 2019 | - | $126.88 M(-412.9%) | $199.56 M(+105.0%) |
| June 2019 | - | -$40.55 M(-67.9%) | $97.35 M(+406.6%) |
| Mar 2019 | - | -$126.40 M(-152.7%) | $19.21 M(-87.5%) |
| Dec 2018 | $153.14 M(+27.7%) | $239.63 M(+871.6%) | $153.14 M(-277.1%) |
| Sept 2018 | - | $24.66 M(-120.8%) | -$86.49 M(-22.2%) |
| June 2018 | - | -$118.68 M(-1676.1%) | -$111.15 M(-1576.1%) |
| Mar 2018 | - | $7.53 M | $7.53 M |
| Dec 2017 | $119.92 M(-1356.2%) | - | - |
| Dec 2016 | -$9.55 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual FCF year-on-year change?
- What is Amneal Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly FCF year-on-year change?
- What is Amneal Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM FCF year-on-year change?
What is Amneal Pharmaceuticals annual free cash flow?
The current annual FCF of AMRX is $276.39 M
What is the all time high annual FCF for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual free cash flow is $312.81 M
What is Amneal Pharmaceuticals annual FCF year-on-year change?
Over the past year, AMRX annual free cash flow has changed by +$301.88 M (+1184.09%)
What is Amneal Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AMRX is $121.06 M
What is the all time high quarterly FCF for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly free cash flow is $239.63 M
What is Amneal Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AMRX quarterly free cash flow has changed by +$53.15 M (+78.27%)
What is Amneal Pharmaceuticals TTM free cash flow?
The current TTM FCF of AMRX is $229.23 M
What is the all time high TTM FCF for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM free cash flow is $407.64 M
What is Amneal Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AMRX TTM free cash flow has changed by +$91.73 M (+66.71%)